Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Amber Bahorik, PhD

    TitlePostdoctoral Scholar
    SchoolUCSF School of Medicine
    Address530 Parnassus Avenue, Library
    San Francisco CA 94143
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of PittsburghPhDSocial Work2015
      University of California San FranciscoPostdoctoral FellowshipPsychiatry; Drug Abuse/Treatment Services and Research 2015

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI, et al. Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med. 2016 Sep 8. PMID: 27610582.
        View in: PubMed
      2. Bahorik AL, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD, et al. The role of hazardous drinking reductions in predicting depression and anxiety symptom improvement among psychiatry patients: A longitudinal study. J Affect Disord. 2016 Jul 19; 206:169-173. PMID: 27475887.
        View in: PubMed
      3. Racial disparities in community outcomes among adults with schizophrenia and comorbid substance use disorders. J SocWork Prac Addict. 2014; 2(15):165-184.
      4. Integrated cognitive enhancement therapy and personal therapy for substance misusing schizophrenia patients: interim results on the first 6 months of treatment. Drug Alcohol Depend. 2014; (140):e53.
      5. Bahorik AL, Cornelius JR, Bangalore SS, Newhill CE, Keshavan MS, Eack SM, et al. BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA. Schizophr Res Cogn. 2014 Sep 1; 1(3):160-163. PMID: 25419516.
        View in: PubMed
      6. Bahorik AL, Newhill CE, Queen CC, Eack SM. Letter to the editor: Critique of Bahorik et al. (2013)--'Underreporting of drug use among individuals with schizophrenia: prevalence and predictors'--a reply. Psychol Med. 2014 Feb; 44(3):670-1. PMID: 24524169.
        View in: PubMed
      7. Eack SM, Greenwald DP, Hogarty SS, Bahorik AL, Litschge MY, Mazefsky CA, Minshew NJ. Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility study. J Autism Dev Disord. 2013 Dec; 43(12):2866-77. PMID: 23619953; PMCID: PMC3773526.
      8. Eack SM, Bahorik AL, Hogarty SS, Greenwald DP, Litschge MY, Mazefsky CA, Minshew NJ. Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapy. J Autism Dev Disord. 2013 Sep; 43(9):2233-7. PMID: 23381484; PMCID: PMC3686872.
      9. Bahorik AL, Newhill CE, Eack SM. Neurocognitive functioning of individuals with schizophrenia: using and not using drugs. Schizophr Bull. 2014 Jul; 40(4):856-67. PMID: 23884348; PMCID: PMC4059433.
      10. Eack SM, Bahorik AL, McKnight SA, Hogarty SS, Greenwald DP, Newhill CE, Phillips ML, Keshavan MS, Minshew NJ. Commonalities in social and non-social cognitive impairments in adults with autism spectrum disorder and schizophrenia. Schizophr Res. 2013 Aug; 148(1-3):24-8. PMID: 23768814; PMCID: PMC3732579.
      11. Bahorik AL, Newhill CE, Queen CC, Eack SM. Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors. Psychol Med. 2014 Jan; 44(1):61-9. PMID: 23551851.
        View in: PubMed
      12. Bahorik AL, Newhill CE, Eack SM. Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction. 2013 Jul; 108(7):1259-69. PMID: 23432626; PMCID: PMC3679358.
      13. Eack SM, Bahorik AL, Newhill CE, Neighbors HW, Davis LE. Interviewer-perceived honesty as a mediator of racial disparities in the diagnosis of schizophrenia. Psychiatr Serv. 2012 Sep 1; 63(9):875-80. PMID: 22751938; PMCID: PMC3718294.
      14. Bahorik AL, Eack SM. Examining the course and outcome of individuals diagnosed with schizophrenia and comorbid borderline personality disorder. Schizophr Res. 2010 Dec; 124(1-3):29-35. PMID: 20888189.
        View in: PubMed
      Amber's Networks
      Related Concepts
      Derived automatically from this person's publications.
      Related Authors
      People who share related concepts with this person.
      Back to TOP